Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Capsules
Patent
1995-06-07
1998-01-13
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Capsules
424458, 424468, 424469, 424470, 424471, 424472, 514415, 514419, A61K 952, A61K 954, A61K 922, A61K 926
Patent
active
057076529
ABSTRACT:
Methods for treating circadian rhythm disorders and sleep disorders are described. The method involves oral administration of a sustained release composition of melatonin to produce a normal melatonin pattern when the normal pattern has been disrupted or is missing.
REFERENCES:
patent: 2853420 (1958-09-01), Lowey
patent: 3538214 (1970-11-01), Polli et al.
patent: 3835221 (1974-09-01), Fulberth et al.
patent: 4083949 (1978-04-01), Benedikt
patent: 4341759 (1982-07-01), Bobentoft et al.
patent: 4505890 (1985-03-01), Tain et al.
patent: 4572833 (1986-02-01), Pedersen et al.
patent: 4600723 (1986-07-01), Short et al.
patent: 4665086 (1987-05-01), Short et al.
patent: 4882137 (1989-11-01), Staples et al.
patent: 4945103 (1990-07-01), Cohen
patent: 5169642 (1992-12-01), Brinker et al.
patent: 5242941 (1993-09-01), Lewy et al.
patent: 5449588 (1995-09-01), Wurtman
Abstract, Lee et al., 1992 "Oral controlled release delivery system which mimics human circadian rhythm of melatonin", Amer. Assoc. Pharmac. Sci. Meeting, San Antonio, TX, Nov. 17, 1992, Abstract PDD 7162.
Abstract, Lee et al., 1992, "Evaluation of an oral controlled release delivery system which mimics human circadian rhythm of melatonin in human subjects", Weatern Pharnacy and Pharmacology Graduate Students' Meeting, Jul. 24, 1992.
Abstract, Lee et al., 1992, "Development of an oral sustained release delivery system for melatonin", Amer. Assoc. Pharmac. Sci. Meeting, Reno, NV, Mar., 1992.
Abstract, Lee et al., 1992, "Evaluation of an oral sustained release delivery system for melatonin in human subjects", Amer. Assoc. Pharmac. Sci. Meeting, Reno, NV, Mar., 1992.
Abstract, Lee et al., "Physicochemical properties of melatonin for dosage form design", Amer. Assoc. Pharmac. Sci. Meeting, Oct. 1991.
Abstract, Lee et al., 1991, "Transdermal delivery of melatonin in human subjects--pilot study", Amer. Assoc. Pharmac. Sci. Meeting, Reno, NV, Feb., 1991.
Lewy et al., 1992, "Melatonin shifts human circadian rhythms according to a phase-response curve", Chronobiol. Int'l 9: 380-392.
Nickelsen et al., 1991, "The effect of 6-, 9- and 11-hour time shifts on circadian rhythms: adaptation of sleep parameters and hormonal patterns following the intake of melatonin of placebo", Adv. Pineal Res. 5: 303-306.
Armstrong, 1991, "Treatment of sleep disorders by melatonin administration", Adv. in Pineal Res. 6: 263-274.
Samel et al., 1991, "Influence of melatonin treatment on human circadian rhythmicity before and after simulated 9-hr time shift", J. Biol. Rhythms 6: 235-248.
Van Coevorden et al., 1991, "Neuroendocrine rhythms and sleep in aging men", Am. J. Physiol. 260 (Endocrinol. Metab. 23):E651-E661.
Dahlitz et al., 1991, "Delayed sleep phase syndrome response to melatonin", The Lancet 337: 1121-1124.
Mallo et al, 1990, "Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection", J. Clin. Pharmacol. 38: 297-301 (1990).
Armstrong, 1989, "Melatonin and circadian control in mammals", Experientia 45: 932-938.
Mallo et al., 1988, "Effects of a four-day nocturnal melatonin treatment on the 24 h plasma melatonin, cortisol and prolactin profiles in humans", Acta Endocrinol. 119: 474-480.
Arendt et al., 1987, "Some effects of jet-lag and their alleviation by melatonin", Ergonomics 30: 1379-1393.
Underwood, 1986, "Circadian Rhythms in Lizards: Phase Response Curve for Melatonin", J. Pineal Res. 3: 187-196.
Aldhous et al., 1985, "Plasma concentrations of melatonin in man following oral absorption of different preparations", Br. J. Clin. Pharmac. 19:517-521.
Arendt et al., 1985, "Some effects of melatonin and the control of its secretion in humans", CIBA Found. Symp. 117: 266-283.
Lane and Moss, 1985, "Pharmocokinetics of melatonin in man: First pass hepatic metabolism", J. Clin. Endocrinol. Metab. 61: 214-1216.
Waldhauser et al., 1984, "Melatonin in human body fluids: Clinical significance", in The Pineal Gland, (R. Reiter, ed.), Raven Press: New York, p. 359.
Arendt et al., 1984, "The effects of chronic, small doses of melatonin given in the late afternoon on fatigue in man: A preliminary study", Neurosci. Lett. 45: 317-325.
Iguchi et al., 1982, "Melatonin serum levels and metabolic clearance rate in patients with liver cirrhosis", J. Clin. Endocrinol. Metab. 54: 1025-1027.
Gwinner, 1978, "The effects of pinealectomy on circadian locomotor activity rhythms in European starlings, Sturnus vulgaris", J. Comp. Physiol. 126: 123-129.
Ayres James W.
Lewy Alfred J.
Parrott Keith A.
Sack Robert L.
Rose Shep K.
State of Oregon
LandOfFree
Methods of treating circadian rhythm phase disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating circadian rhythm phase disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating circadian rhythm phase disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-324199